| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/08830180802432178 |
| P698 | PubMed publication ID | 19065353 |
| P2093 | author name string | Sukhbir Singh | |
| Shiwani Singh | |||
| M Irshad | |||
| I Khushboo | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 | Q24296260 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 | ||
| Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection | Q27469828 | ||
| T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. | Q27469830 | ||
| Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders | Q27472760 | ||
| Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease | Q27473001 | ||
| Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
| PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion | Q27477628 | ||
| Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C | Q27478117 | ||
| Increased hepatitis C virus (HCV)-specific CD4+CD25 + regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels | Q27478131 | ||
| Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C | Q27480306 | ||
| Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell Responses | Q27480368 | ||
| Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition | Q27485138 | ||
| Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions | Q27485145 | ||
| Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses | Q27485419 | ||
| In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes | Q27491029 | ||
| Genetic organization and diversity of the hepatitis C virus | Q27860507 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. | Q29048140 | ||
| Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis | Q29547897 | ||
| A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells | Q29615897 | ||
| Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization | Q29615898 | ||
| Vaccination of chimpanzees against infection by the hepatitis C virus | Q29615899 | ||
| Analysis of a successful immune response against hepatitis C virus | Q29619507 | ||
| Adaptive immune responses in acute and chronic hepatitis C virus infection | Q29619722 | ||
| The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies | Q29619723 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 | ||
| Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
| Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection | Q29620795 | ||
| Lack of Protective Immunity Against Reinfection with Hepatitis C Virus | Q29620909 | ||
| Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins | Q29620952 | ||
| Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. | Q33916582 | ||
| Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection | Q34444955 | ||
| Evolving role of pegylated interferons in metastatic renal cell carcinoma | Q35611876 | ||
| Functional hepatitis C virus envelope glycoproteins | Q35869038 | ||
| Cell-mediated immunity and the outcome of hepatitis C virus infection | Q35919862 | ||
| Neutralizing antibody response during acute and chronic hepatitis C virus infection | Q35971609 | ||
| The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection? | Q36041367 | ||
| Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers | Q36361001 | ||
| A target on the move: innate and adaptive immune escape strategies of hepatitis C virus | Q36368645 | ||
| Flying under the radar: the immunobiology of hepatitis C. | Q36635544 | ||
| Cytotoxic T cells and viral hepatitis | Q37365416 | ||
| Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors | Q40445284 | ||
| A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. | Q40547706 | ||
| Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals | Q40761226 | ||
| Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection | Q40836214 | ||
| Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity | Q41006162 | ||
| The role of immune responses in the pathogenesis of hepatitis C virus infection | Q41681577 | ||
| Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. | Q42820160 | ||
| Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. | Q42982719 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment | Q42998082 | ||
| A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees | Q42998134 | ||
| Role of the specific T-cell response for clearance and control of hepatitis C virus | Q42998171 | ||
| Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. | Q42998350 | ||
| V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen | Q43001791 | ||
| Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages | Q43036009 | ||
| Detection of Hepatitis C Virus RNA in Acute Non-A, Non-B Hepatitis as an Early Diagnostic Tool | Q43038756 | ||
| Identification of hepatitis C virus core domain inducing suppression of allostimulatory capacity of dendritic cells | Q43039060 | ||
| Persistence of HCV despite antibodies to both putative envelope glycoproteins | Q43039410 | ||
| Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients | Q43040687 | ||
| Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees | Q43040977 | ||
| Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children | Q43041183 | ||
| Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes | Q43046853 | ||
| Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease | Q43048446 | ||
| Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C | Q43048770 | ||
| An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. | Q43636357 | ||
| Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection | Q44975291 | ||
| Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection | Q45409693 | ||
| Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection | Q45729692 | ||
| CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons | Q45733148 | ||
| Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells | Q45738814 | ||
| CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained | Q45740431 | ||
| Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity | Q45764886 | ||
| TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). | Q46635338 | ||
| Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. | Q53316441 | ||
| Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. | Q53571602 | ||
| Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. | Q55066427 | ||
| Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection | Q57160316 | ||
| P433 | issue | 6 | |
| P921 | main subject | immunology | Q101929 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 497-517 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | International Reviews of Immunology | Q6052764 |
| P1476 | title | Hepatitis C virus (HCV): a review of immunological aspects | |
| P478 | volume | 27 |
| Q56550464 | A Single-step Multiplex Quantitative Real Time Polymerase Chain Reaction Assay for Hepatitis C Virus Genotypes |
| Q39702687 | Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy |
| Q22305934 | Acute hepatitis C: prevention and treatment |
| Q38168827 | An insight into the diagnosis and pathogenesis of hepatitis C virus infection |
| Q39555726 | Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil |
| Q36172970 | Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C. |
| Q36465097 | Genetic (KIR, HLA-C) and Some Clinical Parameters Influencing the Level of Liver Enzymes and Early Virologic Response in Patients with Chronic Hepatitis C |
| Q34169767 | Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment? |
| Q43168969 | Isoprostane as a marker of oxidative stress in chronic heroin users: correlation with duration of heroin use or concomitant hepatitis C infection |
| Q34530512 | Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors |
| Q37981941 | NF-κB as a potential therapeutic target in microbial diseases |
| Q27490522 | Palmitoylation of Hepatitis C Virus Core Protein Is Important for Virion Production |
| Q50527840 | Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C. |
| Q37558730 | Relationship between humoral response against hepatitis C virus and disease overcome. |
| Q40043091 | Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele. |
| Q26774612 | Status of hepatitis C virus vaccination: Recent update |
| Q43298814 | Tanshinone IIA protects against immune-mediated liver injury through activation of T-cell subsets and regulation of cytokines. |
| Q38842372 | Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System. |
| Q39683662 | Viral fusion peptides induce several signal transduction pathway activations that are essential for interleukin-10 and beta-interferon production |
Search more.